Last updated on April 2019

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of Canagliflozin (TA-7284) in Japanese patients with Diabetic Nephropathy, compared with placebo

Clinical Study Identifier: NCT03436693

Find a site near you

Start Over

Research site

Saitama, Japan
3.55miles
  Connect »

Research site

Tokyo, Japan
9.89miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.